Skip to main content
logo
Cronos Group Inc. (CRON)
NASDAQ: CRON · Real-Time Price · USD
3.100
+0.030 (0.98%)
At close: Aug 7, 2026, 4:00 PM EDT
3.060
-0.040 (-1.29%)
Pre-market: Aug 10, 2026, 7:42 AM EDT

Cronos Group Revenue

Cronos Group had revenue of $53.01M in the quarter ending June 30, 2026, with 58.44% growth. This brings the company's revenue in the last twelve months to $179.09M, up 37.46% year-over-year. In the year 2025, Cronos Group had annual revenue of $146.59M with 24.63% growth.

Revenue (ttm)
$179.09M
Revenue Growth
+37.46%
P/S Ratio
6.47
Revenue / Employee
$293,585
Employees
610
Market Cap
1.16B

Revenue Chart

Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 2025146.59M28.97M24.63%
Dec 31, 2024117.62M30.37M34.82%
Dec 31, 202387.24M492.00K0.57%
Dec 31, 202286.75M22.19M34.37%
Dec 31, 202164.56M17.84M38.19%
Dec 31, 202046.72M22.97M96.71%
Dec 31, 201923.75M11.63M95.94%
Dec 31, 201812.12M8.97M285.16%
Dec 31, 20173.15M--
Dec 31, 2016---
Dec 31, 2015---
Dec 31, 2014-572.29K--

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Related Stocks

Company NameRevenue
Phibro Animal Health1.50B
Trulieve Cannabis1.14B
ANI Pharmaceuticals978.38M
Collegium Pharmaceutical808.21M
Pacira BioSciences746.16M
Amphastar Pharmaceuticals730.02M
Alvotech562.04M
Xeris Biopharma Holdings335.41M
Revenue Rankings

CRON News

More News